Trials / Sponsors / EQRx International, Inc.
EQRx International, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metast Endometrial Carcinoma | Phase 3 | 2023-04-18 |
| Terminated | Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Rec NSCLC | Phase 3 | 2022-12-14 |
| Completed | An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143 Severe Hepatic Impairment | Phase 1 | 2022-03-30 |
| No Longer Available | An Expanded Access Program to Provide Sugemalimab for the Treatment of Relapsed or Refractory Extranodal Natur Extranodal NK/T-cell Lymphoma | — | — |